Brian Rood - Publications

Affiliations: 
2015 Department of Psychology Suffolk University, Boston, MA, United States 

63 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gass BV, Horvath KJ, Marrow E, Rood BA, Pantalone DW. Associations Between Social Support Availability and HIV Risk and Protective Factors in a U.S. Sample of Adults with Diverse Transgender Identities. Lgbt Health. PMID 33370219 DOI: 10.1089/lgbt.2020.0035  1
2020 Petralia F, Tignor N, Reva B, Koptyra M, Chowdhury S, Rykunov D, Krek A, Ma W, Zhu Y, Ji J, Calinawan A, Whiteaker JR, Colaprico A, Stathias V, Omelchenko T, ... ... Rood BR, et al. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. Cell. PMID 33242424 DOI: 10.1016/j.cell.2020.10.044  0.01
2020 Dubuissez M, Paget S, Abdelfettah S, Spruyt N, Dehennaut V, Boulay G, Loison I, de Schutter C, Rood BR, Duterque-Coquillaud M, Leroy X, Leprince D. (Hypermethylated in Cancer 1) modulates the contractile activity of prostate stromal fibroblasts and directly regulates expression. Oncotarget. 11: 4138-4154. PMID 33227080 DOI: 10.18632/oncotarget.27786  0.01
2020 Kambhampati M, Panditharatna E, Yadavilli S, Saoud K, Lee S, Eze A, Almira-Suarez MI, Hancock L, Bonner ER, Gittens J, Stampar M, Gaonkar K, Resnick AC, Kline C, Ho CY, ... ... Rood BR, et al. Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas. Scientific Reports. 10: 10954. PMID 32616776 DOI: 10.1038/S41598-020-67764-2  0.01
2020 Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B, Hall J, Raabe EH, An P, Weingart M, Rood BR, Magge SN, MacDonald TJ, Packer RJ, Nazarian J. Correction to: Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathologica. PMID 32562017 DOI: 10.1007/s00401-020-02162-6  0.01
2020 Hughto JMW, Gunn HA, Rood BA, Pantalone DW. Social and Medical Gender Affirmation Experiences Are Inversely Associated with Mental Health Problems in a U.S. Non-Probability Sample of Transgender Adults. Archives of Sexual Behavior. PMID 32215775 DOI: 10.1007/S10508-020-01655-5  1
2020 Packer RJ, Iavarone A, Jones DTW, Blakeley JO, Bouffet E, Fisher MJ, Hwang E, Hawkins C, Kilburn L, MacDonald T, Pfister SM, Rood B, Rodriguez FJ, Tabori U, Ramaswamy V, et al. Implications of New Understandings of Gliomas in Children and Adults with NF1: Report of a Consensus Conference. Neuro-Oncology. PMID 32055852 DOI: 10.1093/Neuonc/Noaa036  0.01
2019 Rivero-Hinojosa S, Kinney N, Garner HR, Rood BR. Germline Microsatellite Genotypes Differentiate Children with Medulloblastoma. Neuro-Oncology. PMID 31562520 DOI: 10.1093/neuonc/noz179  0.01
2019 Tao R, Murad N, Xu Z, Zhang P, Okonechnikov K, Kool M, Rivero-Hinojosa S, Lazarski C, Zheng P, Liu Y, Eberhart CG, Rood BR, Packer R, Pei Y. MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research. PMID 30862721 DOI: 10.1158/0008-5472.Can-18-1787  0.01
2018 Rivero-Hinojosa S, Lau LS, Stampar M, Staal J, Zhang H, Gordish-Dressman H, Northcott PA, Pfister SM, Taylor MD, Brown KJ, Rood BR. Proteomic analysis of Medulloblastoma reveals functional biology with translational potential. Acta Neuropathologica Communications. 6: 48. PMID 29880060 DOI: 10.1186/s40478-018-0548-7  0.01
2018 Rood BA, Kochaver JJ, McConnell EA, Ott MQ, Pantalone DW. Minority Stressors Associated with Sexual Risk Behaviors and HIV Testing in a U.S. Sample of Transgender Individuals. Aids and Behavior. PMID 29464427 DOI: 10.1007/s10461-018-2054-0  1
2017 Katz-Wise SL, Budge SL, Fugate E, Flanagan K, Touloumtzis C, Rood B, Perez-Brumer A, Leibowitz S. Transactional Pathways of Transgender Identity Development in Transgender and Gender Nonconforming Youth and Caregivers from the Trans Youth Family Study. The International Journal of Transgenderism. 18: 243-263. PMID 29527139 DOI: 10.1080/15532739.2017.1304312  0.01
2017 Rood BA, Maroney MR, Puckett JA, Berman AK, Reisner SL, Pantalone DW. Identity concealment in transgender adults: A qualitative assessment of minority stress and gender affirmation. The American Journal of Orthopsychiatry. 87: 704-713. PMID 29154610 DOI: 10.1037/ort0000303  1
2017 Freese R, Ott MQ, Rood BA, Reisner SL, Pantalone DW. Distinct Coping Profiles Are Associated With Mental Health Differences in Transgender and Gender Nonconforming Adults. Journal of Clinical Psychology. PMID 28608524 DOI: 10.1002/Jclp.22490  1
2017 Morrissy AS, Cavalli FM, Remke M, Ramaswamy V, Shih DJ, Holgado BL, Farooq H, Donovan LK, Garzia L, Agnihotri S, Kiehna EN, Mercier E, Mayoh C, Papillon-Cavanagh S, Nikbakht H, ... ... Rood BR, et al. Spatial heterogeneity in medulloblastoma. Nature Genetics. PMID 28394352 DOI: 10.1038/Ng.3838  0.01
2017 Paget S, Dubuissez M, Dehennaut V, Nassour J, Harmon BT, Spruyt N, Loison I, Abbadie C, Rood BR, Leprince D. HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs). Oncotarget. 8: 2916-2935. PMID 27935866 DOI: 10.18632/oncotarget.13807  0.01
2016 Rood BA, Reisner SL, Surace FI, Puckett JA, Maroney MR, Pantalone DW. Expecting Rejection: Understanding the Minority Stress Experiences of Transgender and Gender-Nonconforming Individuals. Transgender Health. 1: 151-164. PMID 29159306 DOI: 10.1089/trgh.2016.0012  1
2016 Staal JA, Pei Y, Rood BR. A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors. International Journal of Molecular Sciences. 17. PMID 27775567 DOI: 10.3390/ijms17101744  0.01
2015 Rood BA, Puckett JA, Pantalone DW, Bradford JB. Predictors of Suicidal Ideation in a Statewide Sample of Transgender Individuals. Lgbt Health. 2: 270-5. PMID 26788676 DOI: 10.1089/Lgbt.2013.0048  1
2015 Waye S, Naeem A, Choudhry MU, Parasido E, Tricoli L, Sivakumar A, Mikhaiel JP, Yenugonda V, Rodriguez OC, Karam SD, Rood BR, Avantaggiati ML, Albanese C. The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells. Aging. 7: 854-68. PMID 26540407  1
2015 Rood BA, McConnell EA, Pantalone DW. Distinct Coping Combinations are Associated with Depression and Support Service Utilization in Men who have Sex with Men Living with HIV. Psychology of Sexual Orientation and Gender Diversity. 2: 96-105. PMID 26042226 DOI: 10.1037/Sgd0000091  1
2015 Staal JA, Lau LS, Zhang H, Ingram WJ, Hallahan AR, Northcott PA, Pfister SM, Wechsler-Reya RJ, Rusert JM, Taylor MD, Cho YJ, Packer RJ, Brown KJ, Rood BR. Proteomic profiling of high risk medulloblastoma reveals functional biology. Oncotarget. 6: 14584-95. PMID 25970789 DOI: 10.18632/Oncotarget.3927  1
2015 Bhatia S, Baig NA, Timofeeva O, Pasquale EB, Hirsch K, MacDonald TJ, Dritschilo A, Lee YC, Henkemeyer M, Rood B, Jung M, Wang XJ, Kool M, Rodriguez O, Albanese C, et al. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization. Oncotarget. 6: 8929-46. PMID 25879388 DOI: 10.18632/Oncotarget.3369  1
2015 Packer RJ, Rood BR, Turner DC, Stewart CF, Fisher M, Smith C, Young-Pouissant T, Goldman S, Lulla R, Banerjee A, Pollack I, Kun L, Onar-Thomas A, Wu S, Boyett JM, et al. Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study. Journal of Neuro-Oncology. 121: 217-24. PMID 25407389 DOI: 10.1007/s11060-014-1665-1  1
2015 Gefter JR, Rood BA, Valentine SE, Bankoff SM, Pantalone DW. Why does it happen? Explanations for men’s violence against women by women with interpersonal victimization histories Journal of Gender Studies. DOI: 10.1080/09589236.2015.1090305  1
2014 Harper GW, Bruce D, Hosek SG, Fernandez MI, Rood BA. Resilience processes demonstrated by young gay and bisexual men living with HIV: implications for intervention. Aids Patient Care and Stds. 28: 666-76. PMID 25329778 DOI: 10.1089/Apc.2013.0330  1
2014 Karunasena E, McIver LJ, Rood BR, Wu X, Zhu H, Bavarva JH, Garner HR. Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas. Oncotarget. 5: 6003-14. PMID 25153720 DOI: 10.18632/Oncotarget.2076  0.01
2014 Avery RA, Hwang EI, Ishikawa H, Acosta MT, Hutcheson KA, Santos D, Zand DJ, Kilburn LB, Rosenbaum KN, Rood BR, Schuman JS, Packer RJ. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. Jama Ophthalmology. 132: 265-71. PMID 24435762 DOI: 10.1001/Jamaophthalmol.2013.7649  1
2014 Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B, Hall J, Raabe EH, An P, Weingart M, Rood BR, Magge SN, MacDonald TJ, Packer RJ, Nazarian J. Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathologica. 127: 881-95. PMID 24297113 DOI: 10.1007/S00401-013-1218-2  1
2014 Pantalone DW, Rood BA, Morris BW, Simoni JM. A systematic review of the frequency and correlates of partner abuse in HIV-infected women and men who partner with men. The Journal of the Association of Nurses in Aids Care : Janac. 25: S15-35. PMID 24070646 DOI: 10.1016/J.Jana.2013.04.003  1
2013 Dubuissez M, Faiderbe P, Pinte S, Dehennaut V, Rood BR, Leprince D. The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1). Biochemical and Biophysical Research Communications. 440: 424-30. PMID 24076391 DOI: 10.1016/j.bbrc.2013.09.091  0.01
2013 Rood BR, Leprince D. Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics. Expert Opinion On Therapeutic Targets. 17: 811-27. PMID 23566242 DOI: 10.1517/14728222.2013.788152  0.01
2013 Yeo KK, Puscasiu E, Keating RF, Rood BR. Durable response of intracranial cellular hemangioma to bevacizumab and temozolomide. Journal of Neurosurgery. Pediatrics. 11: 682-6. PMID 23540527 DOI: 10.3171/2013.2.PEDS12421  0.01
2013 Albanese C, Rodriguez OC, VanMeter J, Fricke ST, Rood BR, Lee Y, Wang SS, Madhavan S, Gusev Y, Petricoin EF, Wang Y. Preclinical magnetic resonance imaging and systems biology in cancer research: current applications and challenges. The American Journal of Pathology. 182: 312-8. PMID 23219428 DOI: 10.1016/J.Ajpath.2012.09.024  1
2013 Hwang EI, Jakacki RI, Fisher MJ, Kilburn LB, Horn M, Vezina G, Rood BR, Packer RJ. Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatric Blood & Cancer. 60: 776-82. PMID 22976922 DOI: 10.1002/pbc.24297  0.01
2013 Yalon M, Rood B, MacDonald TJ, McCowage G, Kane R, Constantini S, Packer RJ. A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG). Pediatric Blood & Cancer. 60: 71-6. PMID 22434731 DOI: 10.1002/pbc.24142  0.01
2013 Gefter JR, Bankoff SM, Valentine SE, Rood BA, Pantalone DW. Feminist Beliefs Associated with Young Women's Recovery from Male-Perpetrated Abuse Women and Therapy. 36: 332-355. DOI: 10.1080/02703149.2013.799987  1
2012 Sirajuddin P, Das S, Ringer L, Rodriguez OC, Sivakumar A, Lee YC, Üren A, Fricke ST, Rood B, Ozcan A, Wang SS, Karam S, Yenugonda V, Salinas P, Petricoin E, et al. Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. Cell Cycle (Georgetown, Tex.). 11: 3801-9. PMID 22983062 DOI: 10.4161/Cc.21988  1
2012 Brown KJ, Formolo CA, Seol H, Marathi RL, Duguez S, An E, Pillai D, Nazarian J, Rood BR, Hathout Y. Advances in the proteomic investigation of the cell secretome. Expert Review of Proteomics. 9: 337-45. PMID 22809211 DOI: 10.1586/Epr.12.21  1
2012 Saratsis AM, Yadavilli S, Magge S, Rood BR, Perez J, Hill DA, Hwang E, Kilburn L, Packer RJ, Nazarian J. Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Neuro-Oncology. 14: 547-60. PMID 22492959 DOI: 10.1093/neuonc/nos067  1
2012 Boulay G, Malaquin N, Loison I, Foveau B, Van Rechem C, Rood BR, Pourtier A, Leprince D. Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation. The Journal of Biological Chemistry. 287: 5379-89. PMID 22194601 DOI: 10.1074/jbc.M111.304287  0.01
2012 Foveau B, Boulay G, Pinte S, Van Rechem C, Rood BR, Leprince D. The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1). The Journal of Biological Chemistry. 287: 5366-78. PMID 22184117 DOI: 10.1074/jbc.M111.329466  0.01
2011 Dubrovsky L, Wong EC, Perez-Albuerne E, Loechelt B, Kamani N, Sande J, Mintz K, Paul W, Luban NL, Rood BR, Fry T. CD34⁺ collection efficiency as a function of blood volumes processed in pediatric autologous peripheral blood stem cell collection. Journal of Clinical Apheresis. 26: 131-7. PMID 21294153 DOI: 10.1002/jca.20281  0.01
2011 Rajagopal MU, Hathout Y, MacDonald TJ, Kieran MW, Gururangan S, Blaney SM, Phillips P, Packer R, Gordish-Dressman H, Rood BR. Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study. Proteomics. 11: 935-43. PMID 21271676 DOI: 10.1002/Pmic.201000198  1
2011 Chao MM, Packer RJ, Myseros JS, Rood BR. Isolated extracranial recurrence of anaplastic ependymoma. Pediatric Blood & Cancer. 56: 317-8. PMID 20830772 DOI: 10.1002/pbc.22764  0.01
2011 Rogers SK, Gomez CF, Carpenter P, Farley J, Holson D, Markowitz M, Rood B, Smith K, Nigra P. Quality of life for children with life-limiting and life-threatening illnesses: description and evaluation of a regional, collaborative model for pediatric palliative care. The American Journal of Hospice & Palliative Care. 28: 161-70. PMID 20826494 DOI: 10.1177/1049909110380594  1
2010 Gururangan S, Chi SN, Young Poussaint T, Onar-Thomas A, Gilbertson RJ, Vajapeyam S, Friedman HS, Packer RJ, Rood BN, Boyett JM, Kun LE. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3069-75. PMID 20479404 DOI: 10.1200/Jco.2009.26.8789  1
2009 Smith C, Santi M, Rajan B, Rushing EJ, Choi MR, Rood BR, Cornelison R, MacDonald TJ, Vukmanovic S. A novel role of HLA class I in the pathology of medulloblastoma. Journal of Translational Medicine. 7: 59. PMID 19594892 DOI: 10.1186/1479-5876-7-59  0.01
2009 Van Rechem C, Rood BR, Touka M, Pinte S, Jenal M, Guérardel C, Ramsey K, Monté D, Bégue A, Tschan MP, Stephan DA, Leprince D. Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (Hypermethylated in cancer 1) Journal of Biological Chemistry. 284: 20927-20935. PMID 19525223 DOI: 10.1074/jbc.M109.022350  1
2009 Crawford JR, Rood BR, Rossi CT, Vezina G. Medulloblastoma associated with novel PTCH mutation as primary manifestation of Gorlin syndrome. Neurology. 72: 1618. PMID 19414732 DOI: 10.1212/WNL.0b013e3181a413d6  0.01
2009 Packer RJ, Jakacki R, Horn M, Rood B, Vezina G, MacDonald T, Fisher MJ, Cohen B. Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan. Pediatric Blood & Cancer. 52: 791-5. PMID 19165892 DOI: 10.1002/Pbc.21935  0.01
2009 Pistollato F, Chen HL, Rood BR, Zhang HZ, D'Avella D, Denaro L, Gardiman M, te Kronnie G, Schwartz PH, Favaro E, Indraccolo S, Basso G, Panchision DM. Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma. Stem Cells (Dayton, Ohio). 27: 7-17. PMID 18832593 DOI: 10.1634/Stemcells.2008-0402  1
2009 Fleuriel C, Touka M, Boulay G, Guérardel C, Rood BR, Leprince D. HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors. The International Journal of Biochemistry & Cell Biology. 41: 26-33. PMID 18723112 DOI: 10.1016/j.biocel.2008.05.028  0.01
2008 Choi LM, Rood B, Kamani N, La Fond D, Packer RJ, Santi MR, Macdonald TJ. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors. Pediatric Blood & Cancer. 50: 970-5. PMID 17941070 DOI: 10.1002/Pbc.21381  0.01
2007 Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue Pediatric Blood and Cancer. 48: 278-284. PMID 16456857 DOI: 10.1002/pbc.20781  1
2005 Rood BR, MacDonald TJ. Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches. Journal of Neuro-Oncology. 75: 267-72. PMID 16195804 DOI: 10.1007/S11060-005-6749-5  0.01
2004 Rood BR, Macdonald TJ, Packer RJ. Current treatment of medulloblastoma: recent advances and future challenges. Seminars in Oncology. 31: 666-75. PMID 15497120 DOI: 10.1053/J.Seminoncol.2004.07.009  0.01
2004 Rood BR, Zhang H, Cogen PH. Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma. Neuro-Oncology. 6: 200-7. PMID 15279712 DOI: 10.1215/S1152851703000565  0.01
2004 Pinte S, Stankovic-Valentin N, Deltour S, Rood BR, Guérardel C, Leprince D. The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties. The Journal of Biological Chemistry. 279: 38313-24. PMID 15231840 DOI: 10.1074/jbc.M401610200  0.01
2003 Chopra A, Brown KM, Rood BR, Packer RJ, MacDonald TJ. The use of gene expression analysis to gain insights into signaling mechanisms of metastatic medulloblastoma. Pediatric Neurosurgery. 39: 68-74. PMID 12845196 DOI: 10.1159/000071317  0.01
2003 Packer RJ, Rood BR, MacDonald TJ. Medulloblastoma: present concepts of stratification into risk groups. Pediatric Neurosurgery. 39: 60-7. PMID 12845195  0.01
2003 MacDonald TJ, Rood BR, Santi MR, Vezina G, Bingaman K, Cogen PH, Packer RJ. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors. The Oncologist. 8: 174-86. PMID 12697942  0.01
2002 Rood BR, Zhang H, Weitman DM, Cogen PH. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Research. 62: 3794-7. PMID 12097291  0.01
Show low-probability matches.